# Reinhard Hohlfeld

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/reinhard-hohlfeld/

## Facts

| Field | Value |
| --- | --- |
| Citations | 35,362 |
| Field | Multiple Sclerosis Research Studies |
| h-index | 99 |
| i10-index | 280 |
| Last Known Institution | Munich Cluster for Systems Neurology |
| OpenAlex ID | https://openalex.org/A5028689651 |
| ORCID iD | https://orcid.org/0000-0002-6302-1488 |
| Works | 550 |

## Researcher papers

- [Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension](https://scholariq.org/papers/effect-of-natalizumab-on-disease-progression-in-secondary-progressive-multiple/)
- [Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis](https://scholariq.org/papers/autoantibodies-to-mog-in-a-distinct-subgroup-of-adult-multiple-sclerosis/)
- [Histopathology and clinical course of MOG-antibody-associated encephalomyelitis](https://scholariq.org/papers/histopathology-and-clinical-course-of-mog-antibody-associated-encephalomyelitis/)

## Researcher topics

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Myasthenia Gravis and Thymoma](https://scholariq.org/topics/myasthenia-gravis-and-thymoma/)

## Researcher university

- [Munich Cluster for Systems Neurology](https://scholariq.org/institutions/munich-cluster-for-systems-neurology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.